Spinal Implants
Search documents
Orthofix(OFIX) - 2025 Q3 - Earnings Call Presentation
2025-11-04 13:30
Financial Performance (Q3 2025) - Reported net sales increased by 4.6% to $205.6 million compared to $196.6 million in Q3 2024[2,5] - Pro forma net sales (excluding M6 product lines) increased by 6.3% to $203.4 million compared to $191.3 million in Q3 2024[2] - Bone Growth Therapies net sales increased by 5.7% to $61.2 million[2] - Spinal Implants, Biologics and Enabling Technologies net sales increased by 5.6% to $108.6 million[2] - Global Orthopedics net sales increased by 10.1% to $33.6 million[2] - Adjusted EBITDA increased to $25.114 million, representing 12.2% of reported net sales, compared to $19.180 million or 9.8% in Q3 2024[7] - Pro forma adjusted EBITDA increased to $24.582 million, representing 12.1% of pro forma net sales, compared to $17.515 million in Q3 2024[7] Financial Performance (YTD 2025) - Net sales increased to $602.401 million from $583.834 million[5] - Adjusted EBITDA increased to $55.241 million, representing 9.2% of reported net sales, compared to $43.478 million or 7.4% in YTD 2024[7] - Free cash flow improved to -$18.099 million compared to -$24.285 million in YTD 2024[9] Balance Sheet (September 30, 2025) - Cash and cash equivalents totaled $62.860 million, down from $83.238 million at the end of 2024[3] - Total assets amounted to $832.610 million, compared to $893.294 million at the end of 2024[3]
Aurora Spine Corporation to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
Globenewswire· 2025-05-28 18:50
Company Participation - Aurora Spine Corporation will participate in the Lytham Partners Spring 2025 Investor Conference, hosting a webcast presentation and one-on-one meetings with investors on May 29, 2025 [1][2][3] Webcast Details - The webcast presentation is scheduled for 10:15 a.m. ET on May 29, 2025, and will be accessible via the conference homepage or directly through a provided link [2] One-on-One Meetings - Management will engage in virtual one-on-one meetings during the event, with arrangements available through Lytham Partners [3] Company Overview - Aurora Spine focuses on innovative, minimally invasive, regenerative spinal implant technologies aimed at improving spinal surgery outcomes [4]
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2025 Financial Results
Globenewswire· 2025-05-19 20:40
Core Viewpoint - Aurora Spine Corporation is set to release its financial results for the first quarter of fiscal year 2025 on May 21, 2025, after market hours, with a press release scheduled for May 22, 2025, before market trading [1]. Financial Results Announcement - The financial results for the first quarter ended March 31, 2025, will be filed with SEDAR [1]. - A conference call for investors will take place on May 22, 2025, at 11:00 a.m. ET / 8:00 a.m. PT to discuss the results [2]. Conference Call Details - Interested parties can join the conference call by dialing (844) 861-5497 or (412) 317-5794 [2]. - A live webcast of the conference call will be available at the provided link [2]. Replay Information - A teleconference replay will be accessible until May 29, 2025, with specific access codes provided [3]. - The webcast replay will be available for 90 days at the specified link [3]. Company Overview - Aurora Spine focuses on innovative, minimally invasive, regenerative spinal implant technologies aimed at improving spinal surgery outcomes [4].
Sintx Technologies(SINT) - Prospectus(update)
2023-02-07 11:15
As filed with the Securities and Exchange Commission on February 7, 2023 Registration No. 333-269475 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SINTX Technologies, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 3841 84-1375299 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identificatio ...
Sintx Technologies(SINT) - Prospectus(update)
2023-02-06 14:01
As filed with the Securities and Exchange Commission on February 6, 2023 Registration No. 333-269475 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SINTX Technologies, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 3841 84-1375299 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 1885 West 2100 Sou ...